drugset
drugset / Trial / NCT03945344

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium

NCT03945344 ↗

Phase 1 Completed 20 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

The study will assess how efficiently activated charcoal will block absorption of tiotropium via the gastro intestinal track. Pharmacokinetics of tiotropium will be compared after orally administered tiotropium capsule with and without concomitant activated charcoal administration in healthy volunteers.

Timeline

Start
2019-05-27
Primary completion
2019-06-19
Completion
2019-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 20 ug Oral

Indications

No indication recorded.